SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 128.09 |
| Enterprise Value ($M) | 114.21 |
| Book Value ($M) | 27.76 |
| Book Value / Share | 0.31 |
| Price / Book | 13.53 |
| NCAV ($M) | 24.78 |
| NCAV / Share | 0.27 |
| Price / NCAV | 5.17 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.95 |
| Return on Assets (ROA) | -1.26 |
| Return on Equity (ROE) | -3.19 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.64 |
| Current Ratio | 1.72 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 31.97 |
| Assets | 34.96 |
| Liabilities | 7.20 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -31.51 |
| Net Income | -30.88 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -35.40 |
| Cash from Investing | 0.00 |
| Cash from Financing | 46.76 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Highbridge Capital Management Llc | 9.90 | 537.71 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 433,602 | 2,612,042 | 16.60 | |
| 629,173 | 2,861,297 | 21.99 | |
| 427,390 | 1,960,003 | 21.81 | |
| 343,309 | 1,782,224 | 19.26 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SILO – Silo Pharma, Inc. | SLGL – Sol-Gel Technologies Ltd. |
| SLRX – Salarius Pharmaceuticals, Inc. | SNDL – SNDL Inc. |
| SNGX – Soligenix, Inc. |
Financial data and stock pages provided by
Fintel.io